Global Precision Medicine Market Overview
Precision medicine is a medical approach for disease prevention and treatment which allows medical practitioners to select specific treatments for patients based on the genetic understanding of a particular disease. Recent developments in science and technology have increased the speed of research in this area. The terms precision medicine and personalized medicine often overlap with each other. The precision medicine is based on cellular analysis and molecular analysis and is paving new ways for advanced treatment options which includes specific tailored treatments for patients. It uses many tools which includes imaging, molecular diagnostics and analytics.
There is a wide application of systems biology and panomic analysis to effectively analyze a specific disease at a molecular level and then apply targeted treatments to cure the disease. The response of the patient is closely tracked using tumor load. It is widely used to treat cancer and its branch which addresses cancer is technically referred as precision oncology. Cancer patients often receives a combination of treatments which includes chemotherapy, radiotherapy, cancer immunotherapy and surgery. With the help of precision medicine, information about any kind of genetic changes in the tumor can help the oncologists to decide which type of treatment will work best for the patient.
Market Size and Forecast
The market is observing vibrant growth on account of increasing growth of personal healthcare devices coupled with the rise in the technological advancements in the healthcare sector. Rise in the investment in research and development and increased incidence of various types of cancer are some of the factors that expected to augment the growth of the market. Increasing development in the field of bioinformatics specifically for gene sequencing is also estimated to boost the market growth. Further, various developments in the field of targeted therapy for the treatment of cancer including precision medicines is helping the market to grow. Higher adoption rate of gene therapy in developed nations coupled with increased incidence rate of genetic disorders worldwide such as thalassemia, hemophilia, sickle cell anemia and others are expected to enhance the market growth.
The precision medicine market is anticipated to record a CAGR of 10.6% over the forecast period i.e. 2019-2027. The market is segmented into application such as immunology, CNS, oncology, respiratory medicine, infections & others out of which the oncology segment is expected to witness high growth on account of enhancement in the prevalence of cancer across the globe. Additionally, the high rate of adoption in the field of oncology to treat different types of cancers is supporting the growth of the market.
Get more information on this report: Download Sample PDF
Growth Drivers
Enhancing Prevalence of Cancer
Conventional treatment methods of cancer includes surgery, chemotherapy, radiotherapy and cancer immunotherapy which have some side effects associated with it. With the help of precision medicines, information about various genetic changes in the tumor can effectively help oncologists to decide the best treatment for a cancer patient. According to the report of World Health Organization (WHO), the global cancer burden has increased to 18.1 million new cases and the number of deaths due to cancer was 9.6 million in 2018. The advent of these medicines has paved new roads in the field of oncology. Therefore, the rising prevalence of cancer around the world is anticipated to expand the global precision medicine market over the forecast period.
Increasing Development in the Field of Bioinformatics
Bioinformatics has a fundamental role in the field 0f precision medicine. Bioinformatics helps to understand the genetic sequence of an individual with the help of various techniques which includes high throughput sequencing, shotgun sequencing, Sanger sequencing, Maxam-Gilbert sequencing and others that specifically helps to analyze genetic sequencing which would further help in identifying specific treatment for cancer patients. This enhanced development in the field of bioinformatics is estimated to augment the growth of the market over the forecast period.
Restraints
Security Concerns Related to Data Storage
There are various security concerns associated with the data storage which can cause potential problems. The storage and handling of large volume of genetic sequenced data can be extremely difficult as the leaking of this data of an individual can be used negatively in a variety of ways. Such security issues associated with data storage are anticipated to hinder the growth of the market during the forecast period.
Market Segmentation
Our-in depth analysis of the global precision medicine market includes the following segments:
By Product
- Instruments
- Consumables
- Services
By Technology
- Transcriptomics
- Genomics
- Epigenomics
By Sequencing Technology
- Ion Semiconductor Sequencing
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Chain Termination Sequencing
- Sequencing by Synthesis
- Sequencing by Ligation
- Nanopore Sequencing
By Application
- Immunology
- CNS
- Oncology
- Respiratory Medicine
- Infections
- Others
By End User
- Pharma & Biotech Companies
- Diagnostic Tool Companies
- Big Data Companies
- Clinical Laboratories
By Region
On the basis of regional analysis, the global precision medicine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
North America is expected to dominate the global market of precision medicine on account of increasing cases related to rare genetic disorders and various initiatives taken by the regulatory bodies in support of the market. Further, the rising investment in the research and development in the field of precision medicine coupled with rising healthcare infrastructure are some of the factors augmenting the growth of market in this region.
In the Europe region, Germany is expected to have the largest market share on the back of rising pediatric and adult population susceptible to metabolic diseases. Additionally, rising investment in the healthcare sector by various private and government organizations coupled with various technological advancements is anticipated to boost the market growth over the forecast period.
The global precision medicine market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating The Market
- Bristol-Myers Squibb
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eli Lilly & Company
- Roche Holding AG
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Novartis AG
- AstraZeneca
- QIAGEN
- Quest Diagnostics
- Pfizer Inc.
- Other Prominent Players
